Exhibit 4.1 FORM OF WARRANT THIS WARRANT IS SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANTWarrant Agreement • April 15th, 2004 • Hybridon Inc • Biological products, (no disgnostic substances) • Delaware
FIRST SUPPLEMENTAL INDENTUREFirst Supplemental Indenture • January 15th, 1998 • Hybridon Inc • Biological products, (no disgnostic substances) • New York
THE TERMS OF THIS NOTE ARE SUBJECT TO THE TERMS OF A SUBSCRIPTION AGREEMENT AND AN INTERCREDITOR AGREEMENT, COPIES OF WHICH ARE AVAILABLE FROM HYBRIDON, INC. (THE "COMPANY"). THE SECURITIES REPRESENTED BY THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE...Subscription Agreement • February 15th, 2000 • Hybridon Inc • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT 10.73 SHARE PURCHASE AGREEMENT FOR THE PURCHASE OF COMMON SHARES OF METHYLGENE INC.Share Purchase Agreement • August 20th, 2001 • Hybridon Inc • Biological products, (no disgnostic substances) • Quebec
HYBRIDON, INC.,Indenture • April 14th, 1997 • Hybridon Inc • Biological products, (no disgnostic substances) • New York
LICENSE AGREEMENTLicense Agreement • December 29th, 2000 • Hybridon Inc • Biological products, (no disgnostic substances) • Delaware
1 Exhibit No. 10.65 Mr. E. Andrews Grinstead 33 Edgehill Road Brookline, MA 02446 Dear Andy: This letter sets forth the terms we have agreed upon with respect to your termination of employment from Hybridon, Inc. ("Hybridon" or the "Company"). This...Termination Agreement • April 13th, 2001 • Hybridon Inc • Biological products, (no disgnostic substances)
2 annum per rentable square foot of the Building; for the next five years commencing on the fifth anniversary of the Commencement Date, Forty-Two and 73/100 Dollars ($42.73) per annum per rentable square foot of the Building; for the next five years...Lease • August 15th, 1997 • Hybridon Inc • Biological products, (no disgnostic substances)
Exhibit 10.2 HYBRIDON, INC. EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT ("Agreement") is entered into by and between Robert G. Andersen ("Executive") and Hybridon, Inc., a Delaware corporation (the "Company"), and is effective as of the 1st day of...Employment Agreement • May 14th, 2002 • Hybridon Inc • Biological products, (no disgnostic substances) • Massachusetts
FROMStock Purchase Agreement • April 13th, 2001 • Hybridon Inc • Biological products, (no disgnostic substances) • California
SUBSCRIPTION AGREEMENT SUBSCRIPTION AGREEMENT (this "Agreement"), dated as of December 13, 1999, by and among HYBRIDON, INC., a Delaware corporation (the "Company"), and the Persons listed on the signature pages hereof (the "Current Purchasers") and...Subscription Agreement • February 15th, 2000 • Hybridon Inc • Biological products, (no disgnostic substances) • Massachusetts
Exhibit 10.34 FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT This Fifth Amendment is made, effective as of the 4th day of December, 1998, to that certain Loan and Security Agreement between Hybridon, Inc., a Delaware corporation with a principal place...Loan and Security Agreement • April 15th, 1999 • Hybridon Inc • Biological products, (no disgnostic substances) • Massachusetts
LOAN AGREEMENTLoan Agreement • November 15th, 1999 • Hybridon Inc • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT 10.1 AMENDMENT NO. 1 TO THE COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • November 13th, 2006 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
EXHIBIT 9(a)(2) HYBRIDON, INC. EXCHANGE AGREEMENT AND LETTER OF TRANSMITTAL TO TENDER AND TO ENTER INTO CERTAIN AGREEMENTS IN RESPECT OF ITS 9% CONVERTIBLE SUBORDINATED NOTES DUE 2004 IN EXCHANGE FOR ITS SERIES A PREFERRED STOCK AND EXCHANGE WARRANTS...Exchange Agreement • February 6th, 1998 • Hybridon Inc • Biological products, (no disgnostic substances) • New York
Exhibit 10.43 HYBRIDON, INC. REGISTRATION RIGHTS AGREEMENT dated as of August 28, 2003 HYBRIDON, INC. REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is entered into as of August 28, 2003 by and among Hybridon,...Registration Rights Agreement • October 10th, 2003 • Hybridon Inc • Biological products, (no disgnostic substances) • Delaware
1 Exhibit 10.56 LOAN AND SECURITY AGREEMENT TABLE OF CONTENTSLoan and Security Agreement • March 31st, 1997 • Hybridon Inc • Biological products, (no disgnostic substances) • California
2- 3 unless the holders thereof accept the terms of the underwriting as agreed upon between the Company and/or other holders of shares of Common Stock or other securities of the Company who have initiated the offering pursuant to certain demand...Registration Rights Agreement • March 31st, 1997 • Hybridon Inc • Biological products, (no disgnostic substances) • Massachusetts
1 EXHIBIT 10.2 ------------ HYBRIDON, INC. 620 Memorial Drive Cambridge, MA 02139 May 12, 1997 Pillar S.A. 28, Avenue de Messine 75008 Paris, France Attn: Mr. Youssef El-Zein Re: Consulting Agreement dated as of March 1, 1994 as amended...Consulting Agreement • August 14th, 1997 • Hybridon Inc • Biological products, (no disgnostic substances)
Exhibit 10.7 THIS WARRANT AND THE WARRANT SHARES SHALL NOT BE SOLD OR TRANSFERRED EXCEPT (A) IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE SECURITIES ACT OF 1933, (B) PURSUANT TO REGISTRATION UNDER THE SECURITIES ACT OF 1933 OR (C)...Warrant Agreement • March 29th, 2006 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
INDEMNIFICATION AGREEMENTIndemnification Agreement • May 4th, 2017 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Indemnification Agreement (“Agreement”) is made as of ________ __, 20__ by and between Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and ______________ (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.
1 Exhibit 10.42 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), made this 1st day of March, 1997, is entered into by and between Hybridon, Inc., a Delaware corporation with its principal place of business at One Innovation Drive,...Employment Agreement • March 31st, 1997 • Hybridon Inc • Biological products, (no disgnostic substances) • Massachusetts
Exhibit 10.8 HYBRIDON, INC. REGISTRATION RIGHTS AGREEMENT dated as of May 20, 2005 HYBRIDON, INC. REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "AGREEMENT") is entered into as of May 20, 2005 by and among Hybridon, Inc., a...Registration Rights Agreement • August 9th, 2005 • Hybridon Inc • Biological products, (no disgnostic substances) • Delaware
NEITHER THESE SECURITIES NOR THE COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY APPLICABLE STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED OR OTHERWISE...Warrant Agreement • February 15th, 2000 • Hybridon Inc • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT 10.12 CONSULTING AGREEMENT This Consulting Agreement (the "Agreement") is made and effective as of this 1st day of March, 2003, by and between HYBRIDON, INC., a Delaware corporation with its principal place of business at 345 Vassar Street,...Consulting Agreement • March 31st, 2003 • Hybridon Inc • Biological products, (no disgnostic substances) • Massachusetts
ANDMaster Agreement • August 20th, 2001 • Hybridon Inc • Biological products, (no disgnostic substances) • Delaware
Exhibit 10.9 THIS WARRANT AND THE WARRANT SHARES SHALL NOT BE SOLD OR TRANSFERRED EXCEPT (A) IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE SECURITIES ACT OF 1933, (B) PURSUANT TO REGISTRATION UNDER THE SECURITIES ACT OF 1933 OR (C)...Warrant Agreement • August 9th, 2005 • Hybridon Inc • Biological products, (no disgnostic substances) • Delaware
Exhibit 10.3 FORM OF WARRANT THIS WARRANT AND THE WARRANT SHARES SHALL NOT BE SOLD OR TRANSFERRED EXCEPT (A) IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE SECURITIES ACT OF 1933, (B) PURSUANT TO REGISTRATION UNDER THE SECURITIES ACT OF...Warrant Agreement • November 12th, 2004 • Hybridon Inc • Biological products, (no disgnostic substances) • Delaware
Exhibit 10.47 Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. Licensing Agreement This Agreement is made effective this 12th day of March 1999, by and between Integrated DNA...Licensing Agreement • April 15th, 1999 • Hybridon Inc • Biological products, (no disgnostic substances) • Illinois
ANDWarrant Agreement • April 14th, 1997 • Hybridon Inc • Biological products, (no disgnostic substances) • New York
June 23, 2006Registration Rights Agreement • August 14th, 2006 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
3 SEILER EMPLOYMENT AGREEMENTEmployment Agreement • November 14th, 2001 • Hybridon Inc • Biological products, (no disgnostic substances) • Massachusetts
Exhibit 10.1 LICENSE AGREEMENT THIS LICENSE AGREEMENT dated as of September 7, 1999 (the "Agreement") is made between Hybridon Inc., a corporation organized under the laws of the State of Delaware ("Hybridon"), and Genzyme Corporation, a corporation...License Agreement • November 15th, 1999 • Hybridon Inc • Biological products, (no disgnostic substances) • Massachusetts
ANDRegistration Rights Agreement • April 14th, 1997 • Hybridon Inc • Biological products, (no disgnostic substances) • New York
IDERA PHARMACEUTICALS, INC. SALES AGREEMENTSales Agreement • April 13th, 2012 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Idera Pharmaceuticals, Inc. (the “Company”) confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
